XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 276 shares, a decline of 50.4% from the June 15th total of 556 shares. Based on an average trading volume of 3,957 shares, the days-to-cover ratio is presently 0.1 days.
XOMA Price Performance
XOMAP stock opened at $24.98 on Thursday. XOMA has a fifty-two week low of $24.93 and a fifty-two week high of $30.00. The firm’s 50-day simple moving average is $25.33 and its 200 day simple moving average is $25.88.
XOMA Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 14th. Investors of record on Thursday, July 2nd were given a $0.5391 dividend. This represents a $2.16 annualized dividend and a yield of 8.6%. The ex-dividend date was Thursday, July 2nd.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Further Reading
- Five stocks we like better than XOMA
- Which Storage Stock Is Best Positioned to Win the AI Memory War?
- Tesla’s Delivery Surprise Was Big—Earnings Need to Be Bigger
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
